These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22654213)

  • 1. Structure, control and regulation of the formal market for medicinal plants' products in Nigeria.
    Oguntade AE; Oluwalana IB
    Afr J Tradit Complement Altern Med; 2011; 8(4):370-6. PubMed ID: 22654213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of genotoxicity of herbal medicinal products: a co-ordinated approach.
    Kelber O; Steinhoff B; Kraft K;
    Phytomedicine; 2012 Mar; 19(5):472-6. PubMed ID: 22301069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Future development of global regulations of Chinese herbal products.
    Fan TP; Deal G; Koo HL; Rees D; Sun H; Chen S; Dou JH; Makarov VG; Pozharitskaya ON; Shikov AN; Kim YS; Huang YT; Chang YS; Jia W; Dias A; Wong VC; Chan K
    J Ethnopharmacol; 2012 Apr; 140(3):568-86. PubMed ID: 22373513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Legal requirements for the quality of herbal substances and herbal preparations for the manufacturing of herbal medicinal products in the European union.
    Vlietinck A; Pieters L; Apers S
    Planta Med; 2009 Jun; 75(7):683-8. PubMed ID: 19204891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of medicinal plants for public health--European community monographs on herbal substances.
    Knöss W; Chinou I
    Planta Med; 2012 Aug; 78(12):1311-6. PubMed ID: 22618374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The legal framework governing the quality of (traditional) herbal medicinal products in the European Union.
    Kroes BH
    J Ethnopharmacol; 2014 Dec; 158 Pt B():449-53. PubMed ID: 25086408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granting marketing authorisation for medicines in South East European countries: the point of view of the authority.
    Tomić S; Sucić AF; Martinac AI
    Regul Toxicol Pharmacol; 2010; 57(2-3):325-32. PubMed ID: 20385190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The regulatory framework for complementary and alternative medicines in Europe].
    Knöss W; Stolte F; Reh K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Jul; 51(7):771-8. PubMed ID: 18584103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Food supplements : Legal requirements, borderline issues and other aspects].
    Noble P
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Mar; 60(3):260-267. PubMed ID: 28070624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-European traditional herbal medicines in Europe: a community herbal monograph perspective.
    Qu L; Zou W; Zhou Z; Zhang T; Greef J; Wang M
    J Ethnopharmacol; 2014 Oct; 156():107-14. PubMed ID: 25169214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicinal Product Regulation: Portugal׳s Framework.
    Herdeiro MT; Bastos PD; Teixeira-Rodrigues A; Roque F
    Clin Ther; 2016 Sep; 38(9):2118-2126.e2. PubMed ID: 27574988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicinal plants and their preparations in the European market: Why has the harmonization failed? The cases of St. John's wort, valerian, ginkgo, ginseng, and green tea.
    Bilia AR; Costa MDC
    Phytomedicine; 2021 Jan; 81():153421. PubMed ID: 33291029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with success of market authorisation applications for pharmaceutical drugs submitted to the European Medicines Agency.
    Regnstrom J; Koenig F; Aronsson B; Reimer T; Svendsen K; Tsigkos S; Flamion B; Eichler HG; Vamvakas S
    Eur J Clin Pharmacol; 2010 Jan; 66(1):39-48. PubMed ID: 19936724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European regulation of herbal medicinal products on the border area to the food sector.
    Quintus C; Schweim HG
    Phytomedicine; 2012 Feb; 19(3-4):378-81. PubMed ID: 22070985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Review of the development in European Legislation on the harmonisation of the laws for medicinal products].
    Lehmann B
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Jul; 51(7):713-21. PubMed ID: 18584107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Food supplements on the Hungarian market: regulations of marketing and of the composition of the products].
    Lugasi A; Horacsek M; Martos E
    Orv Hetil; 2010 Sep; 151(39):1563-72. PubMed ID: 20840912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New European commission regulation on variations to the terms of marketing authorization for medicinal products and its impact on Croatian legislation.
    Martinac AI; Tomić S; Simicić M
    Arh Hig Rada Toksikol; 2010 Sep; 61(3):311-22. PubMed ID: 20860972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Marketability of food supplements - criteria for the legal assessment].
    Breitweg-Lehmann E
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Mar; 60(3):277-285. PubMed ID: 28078356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Where is industry getting it wrong? A review of quality concerns raised at Day 120 by the Committee For Medicinal Products for Human Use during European Centralised Marketing Authorisation Submissions for Chemical Entity Medicinal Products.
    Borg JJ; Robert JL; Wade G; Aislaitner G; Pirozynski M; Abadie E; Salmonson T; Vella Bonanno P
    J Pharm Pharm Sci; 2009; 12(2):181-98. PubMed ID: 19732496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulations applicable to plant food supplements and related products in the European Union.
    Silano V; Coppens P; Larrañaga-Guetaria A; Minghetti P; Roth-Ehrang R
    Food Funct; 2011 Dec; 2(12):710-9. PubMed ID: 21997496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.